Literature DB >> 15253942

Glucocorticoid treatment and cardiovascular disease.

M K C Ng, D S Celermajer.   

Abstract

The propensity of glucocorticoids to produce hyperglycaemia, hypertension, dyslipidaemia, and central obesity has long been a cause for concern among physicians regarding possible adverse cardiovascular events. Should heart failure be added to this list of concerns?

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15253942      PMCID： PMC1768346          DOI： 10.1136/hrt.2003.031492

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  21 in total

Review 1.  Aldosterone in congestive heart failure.

Authors:  K T Weber
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

2.  Natural course of Cushing's syndrome as compared with the course of rheumatoid arthritis treated by hormones.

Authors:  C M PLOTZ; A I KNOWLTON; C RAGAN
Journal:  Ann Rheum Dis       Date:  1952-12       Impact factor: 19.103

3.  Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat.

Authors:  J A Spath; D L Lane; A M Lefer
Journal:  Circ Res       Date:  1974-07       Impact factor: 17.367

Review 4.  Glucocorticoids and insulin resistance: old hormones, new targets.

Authors:  R C Andrews; B R Walker
Journal:  Clin Sci (Lond)       Date:  1999-05       Impact factor: 6.124

5.  Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase.

Authors:  Ali Hafezi-Moghadam; Tommaso Simoncini; Zequan Yang; Florian P Limbourg; Jean-Christophe Plumier; Michael C Rebsamen; Chung-Ming Hsieh; Dao-Shan Chui; Kennard L Thomas; Alyson J Prorock; Victor E Laubach; Michael A Moskowitz; Brent A French; Klaus Ley; James K Liao
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

Review 6.  Adverse effects of corticosteroids on the cardiovascular system.

Authors:  D E Sholter; P W Armstrong
Journal:  Can J Cardiol       Date:  2000-04       Impact factor: 5.223

7.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

8.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

9.  Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty.

Authors:  A E Villa; L A Guzman; W Chen; G Golomb; R J Levy; E J Topol
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 10.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582
View more
  12 in total

1.  Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Cong-Lin Liu; Yi Wang; Mengyang Liao; Marcela M Santos; Cleverson Fernandes; Galina K Sukhova; Jin-Ying Zhang; Xiang Cheng; Chongzhe Yang; Xiaozhu Huang; Bruce Levy; Peter Libby; Gongxiong Wu; Guo-Ping Shi
Journal:  Transl Res       Date:  2016-02-01       Impact factor: 7.012

Review 2.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

3.  A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; Junhui Zhang; David S Geller
Journal:  J Am Soc Nephrol       Date:  2008-04-23       Impact factor: 10.121

Review 4.  Controversial cardiovascular and hematologic comorbidities in atopic dermatitis.

Authors:  Karan Pandher; Rima I Ghamrawi; Courtney E Heron; Steven R Feldman
Journal:  Arch Dermatol Res       Date:  2021-05-10       Impact factor: 3.017

5.  Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders.

Authors:  Alex Dregan; Phil Chowienczyk; Mariam Molokhia
Journal:  Heart       Date:  2017-06-10       Impact factor: 5.994

6.  Differential action of glucocorticoids on apolipoprotein E gene expression in macrophages and hepatocytes.

Authors:  Violeta Georgeta Trusca; Elena Valeria Fuior; Ioana Madalina Fenyo; Dimitris Kardassis; Maya Simionescu; Anca Violeta Gafencu
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

7.  Cardiac Manifestations in Systemic Lupus Erythematosus: Clinical Correlates of Subclinical Echocardiographic Features.

Authors:  Alaa A A Mohamed; Nevin Hammam; Mona H El Zohri; Tamer A Gheita
Journal:  Biomed Res Int       Date:  2019-01-10       Impact factor: 3.411

Review 8.  Role of Dual-Specificity Phosphatase 1 in Glucocorticoid-Driven Anti-inflammatory Responses.

Authors:  Jessica Hoppstädter; Alaina J Ammit
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

9.  Orthopaedic corticosteroid injections and risk of acute coronary syndrome: a cohort study.

Authors:  Katharine Thomas; Yochai Schonmann
Journal:  Br J Gen Pract       Date:  2021-01-28       Impact factor: 5.386

10.  Factors associated with risk of major adverse cardiovascular events in patients with rheumatoid arthritis: a nationwide, population-based, case-control study.

Authors:  Yen-Ju Chen; Shih-Chia Liu; Kuo-Lung Lai; Kuo-Tung Tang; Ching-Heng Lin; Yi-Ming Chen; Chih-Wei Tseng; Yu-Mei Chang; Donald F Gotcher; Chuang-Chun Chiou; Shao-Jen Weng; Hsin-Hua Chen
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-08-26       Impact factor: 5.346
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.